A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Exclusive manufacturer-reported metrics
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 16
Comprehensive Pages
- 66
US 510(k) Clearances Outlined
- 9
Comprehensive News Stories
Latest Industry News & Trends
10/11/2018
orthopedicpress release
Market Scope Announces Launch of New Website and Entry into Orthopedics
.jpg)
Market Scope, an industry leader for ophthalmic market research, announced today the launch of its new website and the firm’s entry into orthopedics, its second medical vertical. The new Market-Sco...
1/18/2019
breakingophthalmic
US FDA Accepts IND Application for Aerie’s AR-1105, a Dexamethasone Intravitreal Implant
The US FDA has approved Aerie Pharmaceuticals’ investigational new drug (IND) Application for AR-1105 (dexamethasone intravitreal implant) for macular edema due to retinal vein occlusion (RVO), the...
1/18/2019
breakingophthalmic
Glaukos Moving to Aliso Viejo from San Clemente
Glaukos will move its headquarters in May to Aliso Viejo, California, from San Clemente, California, according to an SEC filing. The company will lease three existing office buildings in Aliso Viej...
1/18/2019
breakingophthalmic
Ocular Therapeutix Seeks to Expand Dextenza’s Indication
Ocular Therapeutix has submitted a supplemental new drug application (sNDA) to the US FDA for Dextenza, the Bedford, Massachusetts, company announced Jan. 10. The sNDA seeks to expand the product’s...
1/18/2019
breakingophthalmic
Aerpio Completes Patient Dosing in Phase IIb Study for Diabetic Retinopathy Candidate
Aerpio Pharmaceuticals has completed patient dosing in its Phase IIb clinical trial of AKB-9778 for severe nonproliferative diabetic retinopathy (NPDR), the Cincinnati company announced Jan. 17. AK...
1/18/2019
breakingophthalmic
FDA Accepts Xbrane’s Application to Begin Study of Xlucane, a Biosimilar of Lucentis
.JPG)
Xbrane reported Jan. 18 that the US FDA accepted the company’s application for a pivotal Phase III trial of Xlucane as a biosimilar to Lucentis in patients with wet age-related macular degeneration...
1/18/2019
breakingophthalmic
Akorn Receives US FDA Warning Letter Citing Plant Violations
Akorn has received a warning letter from the US FDA after an inspection of its Decatur, Illinois, manufacturing plant, the Lake Forest, Illinois, company announced Jan. 9. The warning letter lists ...
1/18/2019
newsletterorthopedic
Flexion Announces Positive Results for Phase II Trial of Zilretta
.png)
Massachusetts-based Flexion Therapeutics announced Jan. 2 that its Phase II pharmacokinetic study of Zilretta for OA of the shoulder and hip achieved positive results. Zilretta is the only extended...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.